Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 245

1.

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.

Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M.

J Clin Psychopharmacol. 2002 Feb;22(1):86-90.

PMID:
11799348
[PubMed - indexed for MEDLINE]
2.

[Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].

Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.

Encephale. 2009 Oct;35(5):477-83. doi: 10.1016/j.encep.2007.09.007. Epub 2008 Jun 12. French.

PMID:
19853722
[PubMed - indexed for MEDLINE]
3.

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M.

Psychiatry Res. 2001 Dec 15;105(1-2):45-55.

PMID:
11740974
[PubMed - indexed for MEDLINE]
4.

Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.

Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Meltzer H.

Mol Psychiatry. 2001 Jul;6(4):475-80.

PMID:
11443537
[PubMed - indexed for MEDLINE]
Free Article
5.

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.

Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.

Mol Psychiatry. 2005 Jun;10(6):538-44.

PMID:
15494706
[PubMed - indexed for MEDLINE]
6.
7.

Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.

Constant A, Castera L, Dantzer R, Couzigou P, de Ledinghen V, Demotes-Mainard J, Henry C.

J Clin Psychiatry. 2005 Aug;66(8):1050-7.

PMID:
16086622
[PubMed - indexed for MEDLINE]
8.

Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes.

Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M.

Psychol Med. 2005 Mar;35(3):433-41.

PMID:
15841878
[PubMed - indexed for MEDLINE]
9.

HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment.

Zignego AL, Cozzi A, Carpenedo R, Giannini C, Rosselli M, Biagioli T, Aldinucci A, Laffi G, Moroni F.

Dig Liver Dis. 2007 Sep;39 Suppl 1:S107-11.

PMID:
17936210
[PubMed - indexed for MEDLINE]
10.

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation.

Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S.

Life Sci. 2002 Sep 6;71(16):1837-48.

PMID:
12175700
[PubMed - indexed for MEDLINE]
11.

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH.

Biol Psychiatry. 2003 Nov 1;54(9):906-14.

PMID:
14573318
[PubMed - indexed for MEDLINE]
12.

Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?

Kenis G, Prickaerts J, van Os J, Koek GH, Robaeys G, Steinbusch HW, Wichers M.

Int J Neuropsychopharmacol. 2011 Mar;14(2):247-53. doi: 10.1017/S1461145710000830. Epub 2010 Jul 29.

PMID:
20667172
[PubMed - indexed for MEDLINE]
13.

[Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].

Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Andrzej K.

Psychiatr Pol. 2006 Jul-Aug;40(4):799-808. Polish.

PMID:
17068951
[PubMed - indexed for MEDLINE]
14.

Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.

Neri S, Pulvirenti D, Bertino G.

Clin Drug Investig. 2006;26(11):655-62.

PMID:
17163300
[PubMed - indexed for MEDLINE]
15.

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.

Van Gool AR, Verkerk R, Fekkes D, Bannink M, Sleijfer S, Kruit WH, van der Holt B, Scharpé S, Eggermont AM, Stoter G, Hengeveld MW.

Psychiatry Clin Neurosci. 2008 Oct;62(5):597-602. doi: 10.1111/j.1440-1819.2008.01854.x.

PMID:
18950381
[PubMed - indexed for MEDLINE]
16.

Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study.

Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Janssen G, Schaefer M.

Eur Psychiatry. 2006 Apr;21(3):204-10.

PMID:
16632167
[PubMed - indexed for MEDLINE]
17.

Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.

Pavlović Z, Delić D, Marić NP, Vuković O, Jašović-Gašić M.

Psychiatr Danub. 2011 Dec;23(4):370-7.

PMID:
22075738
[PubMed - indexed for MEDLINE]
Free Article
18.

Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C.

Malaguarnera M, Laurino A, Di Fazio I, Pistone G, Castorina M, Guccione N, Rampello L.

J Interferon Cytokine Res. 2001 May;21(5):273-8.

PMID:
11429157
[PubMed - indexed for MEDLINE]
19.

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R.

Mol Psychiatry. 2002;7(5):468-73.

PMID:
12082564
[PubMed - indexed for MEDLINE]
Free Article
20.

Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol.

Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M.

J Psychosom Res. 2007 Feb;62(2):207-14.

PMID:
17270579
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk